There are mainly two types of Lung Cancer, Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC). SCLC is less common than NSCLC but is more aggressive and typically requires different treatment approaches, such as chemotherapy and radiation therapy.
#healmeplus
Very excited to have Robert Szczepaniak-Sloane present his work in the Kareta Lab about regulators of HLA repression in #SCLC at the SCLC Consortium this past week, hosted at the National Cancer Institute. Sanford Research
As the countdown to the Big Day of Giving on May 2nd continues, with only 4 days left, we are delighted to highlight our team member Muang Saechao, whose dedication as a Mien/Lao Cultural interpreter at SCLC has illuminated our community for over two decades. #BigDayOfGiving
Proud of our The Shields Lab member, Katie Minton, with a successful poster presentation today IU Simon Comprehensive Cancer Center #CancerResearchDay on an exciting novel therapy that is pre-clinically effective in MYC amplified #SCLC .
#ResearchCuresCancer #LCSM #nothingsmallaboutit SmallCellSMASHERS
Paolo Tarantino HS-20093 (B7-H3), which incorporates an unclosed topoisomerase inhibitor, showed a response in SCLC patients pretreated with irinotecan.
Lung Cancer beingmedicos.com/diseases-and-c… #sclc #cancermetastasis #ctscan #lungcancer survival #lungcancer #immunotherapy #chestpain #airpollution #cancersymptoms #earlycancerdetection #coughingupblood #chestXray #lungcancer screening #nsclc
That feeling when the #1, #2, and #7 most impactful Small Cell Lung Cancer publications from National Cancer Institute SCLC Consortium were led by your mentees and Byers Lab Group Leader (out of 200+ publications). Congratulations to Drs. Carl Gay, Triparna Sen (Sen-Lab), and Dr. Allison Stewart. #lcsm
Thank you Peter Ujhazy Peter Ujhazy, National Cancer Institute and all of the Small Cell Lung Cancer Consortium members for a great #SCLC #LCSM meeting. Amazing to see the progress over 10 years since we first met to make a plan to accelerate progress for patients with SCLC.
I'm so pleased to share that work led by
Kathryn Ries Tringale on the 'Prognostic Implications of SCLC Transcriptional Subtyping for CNS Mets' is online at JCO Precision Oncology (ascopubs.org/doi/full/10.12…)!
Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Cancer Center